1. Home
  2. MREO vs MOFG Comparison

MREO vs MOFG Comparison

Compare MREO & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • MOFG
  • Stock Information
  • Founded
  • MREO 2015
  • MOFG 1934
  • Country
  • MREO United Kingdom
  • MOFG United States
  • Employees
  • MREO N/A
  • MOFG N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • MOFG Major Banks
  • Sector
  • MREO Health Care
  • MOFG Finance
  • Exchange
  • MREO Nasdaq
  • MOFG Nasdaq
  • Market Cap
  • MREO 424.5M
  • MOFG 422.7M
  • IPO Year
  • MREO N/A
  • MOFG N/A
  • Fundamental
  • Price
  • MREO $2.41
  • MOFG $28.81
  • Analyst Decision
  • MREO Strong Buy
  • MOFG Buy
  • Analyst Count
  • MREO 7
  • MOFG 2
  • Target Price
  • MREO $7.71
  • MOFG $35.50
  • AVG Volume (30 Days)
  • MREO 1.5M
  • MOFG 102.4K
  • Earning Date
  • MREO 05-19-2025
  • MOFG 04-24-2025
  • Dividend Yield
  • MREO N/A
  • MOFG 3.37%
  • EPS Growth
  • MREO N/A
  • MOFG N/A
  • EPS
  • MREO N/A
  • MOFG N/A
  • Revenue
  • MREO N/A
  • MOFG $76,604,000.00
  • Revenue This Year
  • MREO N/A
  • MOFG $237.51
  • Revenue Next Year
  • MREO $56.11
  • MOFG $5.96
  • P/E Ratio
  • MREO N/A
  • MOFG N/A
  • Revenue Growth
  • MREO N/A
  • MOFG N/A
  • 52 Week Low
  • MREO $1.58
  • MOFG $20.04
  • 52 Week High
  • MREO $5.02
  • MOFG $34.56
  • Technical
  • Relative Strength Index (RSI)
  • MREO 50.36
  • MOFG 56.43
  • Support Level
  • MREO $2.28
  • MOFG $28.17
  • Resistance Level
  • MREO $2.75
  • MOFG $29.63
  • Average True Range (ATR)
  • MREO 0.16
  • MOFG 1.16
  • MACD
  • MREO -0.00
  • MOFG 0.19
  • Stochastic Oscillator
  • MREO 27.66
  • MOFG 78.87

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About MOFG MidWestOne Financial Gp

MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.

Share on Social Networks: